Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy.
Non-invasive assessment of transgenic animals using bioluminescence imaging offers a rapid means of evaluating disease progression in animal models of disease. One of the challenges in the field is to develop models with robust expression to image repetitively live intact animals through solid tissues. The prostate-specific antigen (PSA) promoter is an attractive model for studying gene regulation due to its hormonal response and tissue-specificity permitting us to measure signaling events that occur within the native tissues. The use of the GAL4-VP16 activator offers a powerful means to augment gene expression levels driven by a weak promoter. We have used a two-step transcriptional amplification (TSTA) system to develop a transgenic mouse model to investigate the tissue-specificity and developmental regulation of firefly luciferase (fl) gene expression in living mice using bioluminescence imaging. We employed an enhanced prostate-specific promoter to drive the yeast transcriptional activator, GAL4-VP16 (effector). The reporter construct carries five Gal4 binding sites upstream of the fl gene. We generated a transgenic mouse model using a single vector carrying the effector and reporter constructs. The transgenic mice show prostate-specific expression as early as three weeks of age. The bioluminescence signal in the prostate is significantly higher than in other organs. We also demonstrate that blocking androgen availability can downregulate the fl expression in the prostate. The transgenic mice display normal physical characteristics and developmental behavior, indicating that the high level of GAL4 driven expression is well tolerated. These findings suggest that the GAL4-VP16 transactivator can be used to amplify reporter gene expression from a relatively weak promoter in a transgenic mouse model. The transgenic TSTA model in conjunction with other transgenic cancer models should also help to detect and track malignancies. The strategies developed will be useful for transgenic research in general by allowing for amplified tissue specific gene expression.
Iyer
M
M
The Crump Institute for Molecular Imaging, Department of Molecular & Medical Pharmacology, Stanford University School of Medicine, 318 Campus Drive, IE, Stanford, CA, USA.
Salazar
F B
FB
Lewis
X
X
Zhang
L
L
Wu
L
L
Carey
M
M
Gambhir
S S
SS
D000818:Animals; D001483:Base Sequence; D017931:DNA Primers; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000235:genetics*; D014158:Transcription, Genetic
D017931:DNA Primers; D017430:Prostate-Specific Antigen